COMMUNIQUÉS West-GlobeNewswire

Gemphire Therapeutics Announces Initiation of its First NASH Proof-of-Concept Clinical Trial and its Differentiated NASH Program

21/12/2017 - 12:00

Phase 2a trial will investigate gemcabene in Familial Partial Lipodystrophy (FPL) – a rare genetic disease with characteristic presentation of cardiovascular disease and NASH Gemcabene has a differentiated profile based [...]

Mesoblast Receives FDA Regenerative Medicine Advanced Therapy Designation for Its Cell Therapy in Heart Failure Patients With Left Ventricular Assist Devices

21/12/2017 - 12:00

NEW YORK and MELBOURNE, Australia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Regenerative [...]

Evergreen Receives Health Canada “Confirmation of Readiness to Inspect Letter” and Plans to Begin Construction of a Second Site and Building "A" of a Three Million sq ft Expansion Plan

21/12/2017 - 11:14

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- EVERGREEN MEDICINAL SUPPLY INC. (“EVERGREEN” OR THE “COMPANY”) [...]

Zealand Pharma: Invitation to Capital Market Day in New York on 25 January, and event in Copenhagen on 29 January 2018

21/12/2017 - 10:12

Press release - No. 13/2017 Zealand Pharma: Invitation to Capital Market Day in New York on 25 January, and event in Copenhagen on 29 January 2018 Zealand's management will provide an update on strategy and business [...]

Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2018.

21/12/2017 - 08:47

Latvia, 2017-12-21 08:47 CET (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2018: Consolidated not audited interim report for the 12 months of 2017 - 19.02. [...]

Summit Enters Licence and Commercialisation Agreement with Eurofarma for Latin American Rights to Ridinilazole

21/12/2017 - 08:01

Summit Therapeutics plc ("Summit" or the "Company") SUMMIT ENTERS INTO LICENCE AND COMMERCIALISATION AGREEMENT WITH EUROFARMA FOR LATIN AMERICAN RIGHTS TO RIDINILAZOLE, SUMMIT'S PRECISION ANTIBIOTIC IN DEVELOPMENT FOR [...]

Summit Enters Into Licence and Commercialisation Agreement With Eurofarma for Latin American Rights to Ridinilazole, Summit’s Precision Antibiotic in Development for the Treatment of CDI

21/12/2017 - 08:00

Summit to receive $2.5 million upfront payment Up to $25 million in development, regulatory, pricing and initial sales milestones Summit retains commercial rights to ridinilazole in rest of the world OXFORD, United [...]

Sales of Olainfarm in November Shrink by 10%

21/12/2017 - 07:59

Olaine, 2017-12-21 07:59 CET (GLOBE NEWSWIRE) -- November 2017, consolidated sales Sales, thsnd. EUR Changes to November 2016 Share in total sales Russia 3 563 -33% 35% Latvia 2 643 5% 26% Ukraine 1 542 209% 15% Belarus [...]

Basilea reports that ceftobiprole received QIDP designation from U.S. FDA for the treatment of Staphylococcus aureus bacteremia (SAB)

21/12/2017 - 07:16

Basel, Switzerland, December 21, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) designated its investigational drug ceftobiprole as a Qualified Infectious [...]

ABLYNX ANNOUNCES POSITIVE DATA FROM ITS JAPANESE ETHNO-BRIDGING STUDY OF CAPLACIZUMAB

21/12/2017 - 07:01

Comparable pharmacokinetics (PK) observed in Japanese and Caucasian healthy volunteers Caplacizumab was well-tolerated in all groups GHENT, Belgium, 21 December 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] [...]

Cannabis Wheaton Income Corp. Announces New Joint Venture for Development of World's Largest Indoor Cannabis Facility with Licensed Producer Partner FV Pharma Inc.

21/12/2017 - 06:01

VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

Denali Therapeutics Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease

20/12/2017 - 23:50

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases [...]

Apellis Finalizes Phase 3 Clinical Trial Plans for Geographic Atrophy Treatment with APL-2

20/12/2017 - 23:30

CRESTWOOD, Ky. and CAMBRIDGE, Ma., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Kraig Biocraft Laboratories posts Holiday Letter to Shareholders

20/12/2017 - 23:30

ANN ARBOR, Mich., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, announced that the Company posted a Letter to its [...]

Kalytera Therapeutics, Inc. Announces Closing of Brokered Private Placement

20/12/2017 - 23:13

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO and TEL AVIV, [...]

Aeterna Zentaris Announces FDA Approval of Macrilen™ (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency

20/12/2017 - 23:00

CHARLESTON, S.C., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced [...]

HMS to Present at the J.P. Morgan 36th Annual Healthcare Conference

20/12/2017 - 22:30

IRVING, Texas, Dec. 20, 2017 (GLOBE NEWSWIRE) -- HMS Holdings Corp (NASDAQ: HMSY ) today announced that Bill Lucia, Chairman and CEO, will make a presentation at the J.P. Morgan 36th Annual Healthcare Conference at 8:30 [...]

The Cooper Companies Sets Annual Meeting and Stockholder Record Dates

20/12/2017 - 22:15

PLEASANTON, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that it will hold its next annual meeting of stockholders on Monday, March 19, 2018. Stockholders of record [...]

Mersana Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

20/12/2017 - 22:01

CAMBRIDGE, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]